The 90% effective dose of intrathecal hyperbaric bupivacaine for Cesarean delivery under combined spinal–epidural anesthesia in parturients with super obesity: an up-down sequential allocation study; [La dose efficace à 90 % de bupivacaïne hyperbare intrathécale pour l’accouchement par césarienne sous péri-rachianesthésie combinée chez les personnes parturientes atteintes de super obésité : une étude d’allocation séquentielle en escalier]

被引：0

作者：

Tan H.S. ^{[1
]}

Fuller M.E. ^{[2
]}

Barney E.Z. ^{[2
]}

Diomede O.I. ^{[3
]}

Landreth R.A. ^{[4
]}

Pham T. ^{[5
]}

Rubright S.M. ^{[6
]}

Ernst L. ^{[7
]}

Habib A.S. ^{[7
]}

机构：

[1] Department of Women’s Anaesthesia, KK Women’s and Children’s Hospital, Singapore

[2] Department of Anesthesiology, Duke University Medical Center, Duke University, Durham, NC

[3] Department of Anesthesiology and Perioperative Medicine, Maine Medical Center, Portland, OR

[4] Department of Anesthesiology, University of North Carolina, Chapel Hill, NC

[5] Associated Anesthesiologists Inc., Tulsa, OK

[6] Department of Anesthesiology, University of Utah, Salt Lake City, UT

[7] Division of Women’s Anesthesia, Department of Anesthesiology, Duke University Medical Center, Durham, NC

来源：

Canadian Journal of Anesthesia/Journal canadien d'anesthésie | 2024年 / 71卷 / 5期

关键词：

bupivacaine; combined spinal epidural; neuraxial; spinal; super obesity;

D O I：

10.1007/s12630-024-02705-5

中图分类号：

学科分类号：

摘要：

Purpose: To determine the 90% effective dose (ED90) of intrathecal hyperbaric bupivacaine for Cesarean delivery under combined spinal–epidural anesthesia (CSE) in parturients with super obesity (body mass index [BMI] ≥ 50 kg·m−2). Methods: We enrolled parturients with BMI ≥ 50 kg·m−2 with term, singleton vertex pregnancies undergoing elective Cesarean delivery under CSE. An independent statistician generated the 0.75% hyperbaric bupivacaine dosing regimen in increments of 0.75 mg using a biased-coin up-down sequential allocation technique. This was combined with 15 μg fentanyl, 150 μg morphine, and normal saline to a volume of 2.05 mL. The initial and maximum doses were 9.75 mg and 12 mg, respectively. Participants, clinical team, and outcome assessors were blinded to the dose. The primary outcome was block success, defined as T6 block to pinprick within ten minutes and no intraoperative analgesic supplementation within 90 min of spinal injection. We determined the ED90 using logistic regression. Results: We enrolled 45 parturients and included 42 in the analysis. All doses achieved a T6 level within ten minutes, and the primary outcome occurred in 0/1 (0%) of the 9.75-mg doses, 2/3 (67%) of the 10.5-mg doses, 21/27 (78%) of the 11.25-mg doses, and 11/11 (100%) of the 12-mg doses. The ED90 of hyperbaric bupivacaine was 11.56 mg (95% confidence interval, 11.16 to 11.99). Four parturients (9.5%) had sensory level higher than T2, but none was symptomatic or required general anesthesia. Conclusion: The estimated ED90 of hyperbaric bupivacaine with fentanyl and morphine in parturients with super obesity undergoing Cesarean delivery under CSE was approximately 11.5 mg. Study registration: ClinicalTrials.gov (NCT03781388); first submitted 18 December 2018. © Canadian Anesthesiologists' Society 2024.

引用

页码：570 / 578

页数：8

共 27 条

[1]

Obesity in pregnancy: ACOG Practice Bulletin, Number 230, Obstet Gynecol, 137, pp. e128-e144, (2021)

[2]

Tonidandel A., Booth J., D'Angelo R., Harris L., Tonidandel S., Anesthetic and obstetric outcomes in morbidly obese parturients: a 20-year follow-up retrospective cohort study, Int J Obstet Anesth, 23, pp. 357-364, (2014)

[3]

Tan H.S., Habib A.S., Obesity in women: anaesthetic implications for peri-operative and peripartum management, Anaesthesia, 76, pp. 108-117, (2021)

[4]

Betran A.P., Ye J., Moller A.B., Souza J.P., Zhang J., Trends and projections of Caesarean section rates: global and regional estimates, BMJ Glob Health, 6, (2021)

[5]

Saucedo M., Esteves-Pereira A.P., Pencole L., Et al., Understanding maternal mortality in women with obesity and the role of care they receive: a national case-control study, Int J Obes (Lond), 45, pp. 258-265, (2021)

[6]

Onishi E., Murakami M., Hashimoto K., Kaneko M., Optimal intrathecal hyperbaric bupivacaine dose with opioids for Cesarean delivery: a prospective double-blinded randomized trial, Int J Obstet Anesth, 31, pp. 68-73, (2017)

[7]

Ginosar Y., Mirikatani E., Drover D.R., Cohen S.E., Riley E.T., ED50 and ED95 of intrathecal hyperbaric bupivacaine coadministered with opioids for cesarean delivery, Anesthesiology, 100, pp. 676-682, (2004)

[8]

Lee Y., Balki M., Parkes R., Carvalho J.C., Dose requirement of intrathecal bupivacaine for Cesarean delivery is similar in obese and normal weight women, Rev Bras Anestesiol, 59, pp. 674-683, (2009)

[9]

Tubog T.D., Ramsey V.L., Filler L., Bramble R.S., Minimum effective dose (ED<sub>50</sub> and ED<sub>95</sub>) of intrathecal hyperbaric bupivacaine for Cesarean delivery: a systematic review, AANA J, 86, pp. 348-360, (2018)

[10]

Hogan Q.H., Prost R., Kulier A., Taylor M.L., Liu S., Mark L., Magnetic resonance imaging of cerebrospinal fluid volume and the influence of body habitus and abdominal pressure, Anesthesiology, 84, pp. 1341-1349, (1996)

← 1 2 3 →